Playback speed
10 seconds
2020 ESMO Update on Advanced EGFR-Mutated NSCLC: Mobocertinib (TAK-788), HER3-Directed ADC Patritumab Deruxtecan, EGFR-MET Bispecific Antibody Amivantamab + Lazertinib (3rd Gen TKI)
By
Lung Cancer Europe (LuCE)
FEATURING
Sanjay Popat
By
Lung Cancer Europe (LuCE)
FEATURING
Sanjay Popat
364 views
November 26, 2020
Courtesy of Lung Cancer Europe (LuCE). The full video can be found here: https://www.lungcancereurope.eu/2020/10/16/luce-webinar-esmo-2020-lung-cancer-highlights/
Login to view comments.
Click here to Login